Number of Shares
54,230.00
Current Holdings Value*
$547,180.00
% of Portfolio
2.18%
Total Estimate Gain
$-28,381.50
% of Total Estimate Gain
-3.91%

S&P MidCap 400 Pure Growth Fund's Roivant Sciences Ltd Holding Summary

As of 2025-03-31, RYDEX SERIES FUNDS held 54,230.00 shares of Roivant Sciences Ltd(ROIV), totaling $547,180.00. This investment constitutes 2.18% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0.01% of the outstanding Roivant Sciences Ltd(ROIV) stock.

The initial trade took place in 2024Q4. And since then S&P MidCap 400 Pure Growth Fund has made 1 purchases of ROIV, at an average price of $11.83, for a total of 61,320.00 shares. In addition, there have been 1 sales at an average price of $10.81 for 7,090.00 shares. Based on historical transaction data and ROIV's current price of $11.44, S&P MidCap 400 Pure Growth Fund's estimated gain on his ROIV holdings is $-28,381.50, reflecting a -3.91% gain to date.

S&P MidCap 400 Pure Growth Fund ROIV ($11.44) Holding Chart

S&P MidCap 400 Pure Growth Fund ROIV ($11.44) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1